FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198517872> ?p ?o ?g. }

• W3198517872 abstract "Abstract Background Crizotinib and Temozolomide are the two major chemotherapy drugs used for the treatment of cancers. Crizotinib is used as a target chemotherapy drug in many cancers. It mainly binds on the ATP binding regions of receptor tyrosine kinases (RTKs) targets and inhibits protein phosphorylation, which has already been reported. Temozolomide drug is known as the alkylating agent. Its mechanism of action is the methylation of DNA and thereby inhibiting DNA replication. However, the Temozolomide drug with protein level interaction of Glioblastoma Multiforme (GBM) and Non-small-cell lung carcinoma (NSCLC) of RTKs targets has not been reported so far. In the proposed work, we investigated the molecular level interaction of the Temozolomide drug in C-MET, C-ROS1, and ALK RTKs targets of GBM and NSCLC using an in silico study. We performed comparative analysis studies in both drugs' docked complexes based on their drug properties and complex energy (CE) to identify the better efficacy of the drug. Results From the docking studies, we could identify that the Temozolomide drug bounded protein complexes showed the least complex energy. The most stable complexes were identified from these docking studies by Molecular Dynamic simulation. In the proposed study, we found that the docked complex attained a stable conformation and least energy via solid hydrogen bond interactions between the amino acid residues and the drug at the binding sites of the proteins. The least energy and the hydrogen bond interaction of Temozolomide drug with the amino acid residues of the protein complexes of C-MET, C-ROS1 and ALK protein with their id name are: 2WGJ is − 11305.0830 (PRO1158, MET1160), 3ZBF is − 11,659.6814 (MET2029, GLU2027), and 2XP2 is − 11,734.7565 (ARG1275, ASP 1160, GLU1167). Conclusion Our studies revealed that the Temozolomide drug bounded protein complex showed the least energy when compared to Crizotinib. So it will give better interaction on the binding sites of proteins and thereby provide better inhibition in the treatment of target therapy of GBM and NSCLC." @default.
• W3198517872 created "2021-09-13" @default.
• W3198517872 creator A5000516526 @default.
• W3198517872 creator A5058895960 @default.
• W3198517872 creator A5082768190 @default.
• W3198517872 date "2021-09-08" @default.
• W3198517872 modified "2023-09-24" @default.
• W3198517872 title "Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug" @default.
• W3198517872 cites W1975623001 @default.
• W3198517872 cites W1975825529 @default.
• W3198517872 cites W1980037916 @default.
• W3198517872 cites W2016210396 @default.
• W3198517872 cites W2049390023 @default.
• W3198517872 cites W2072825243 @default.
• W3198517872 cites W2077332797 @default.
• W3198517872 cites W2103447891 @default.
• W3198517872 cites W2111254482 @default.
• W3198517872 cites W2116720928 @default.
• W3198517872 cites W2117399884 @default.
• W3198517872 cites W2122895515 @default.
• W3198517872 cites W2127129900 @default.
• W3198517872 cites W2130479394 @default.
• W3198517872 cites W2132262459 @default.
• W3198517872 cites W2133460211 @default.
• W3198517872 cites W2152630148 @default.
• W3198517872 cites W2154911603 @default.
• W3198517872 cites W2182252225 @default.
• W3198517872 cites W2223660849 @default.
• W3198517872 cites W2470901352 @default.
• W3198517872 cites W2509744641 @default.
• W3198517872 cites W2615638297 @default.
• W3198517872 cites W2759097420 @default.
• W3198517872 cites W2795353688 @default.
• W3198517872 cites W2899070097 @default.
• W3198517872 cites W2902262211 @default.
• W3198517872 cites W2916036960 @default.
• W3198517872 cites W4237236169 @default.
• W3198517872 doi "https://doi.org/10.1186/s43094-021-00323-2" @default.
• W3198517872 hasPublicationYear "2021" @default.
• W3198517872 type Work @default.
• W3198517872 sameAs 3198517872 @default.
• W3198517872 citedByCount "3" @default.
• W3198517872 countsByYear W31985178722022 @default.
• W3198517872 countsByYear W31985178722023 @default.
• W3198517872 crossrefType "journal-article" @default.
• W3198517872 hasAuthorship W3198517872A5000516526 @default.
• W3198517872 hasAuthorship W3198517872A5058895960 @default.
• W3198517872 hasAuthorship W3198517872A5082768190 @default.
• W3198517872 hasBestOaLocation W31985178721 @default.
• W3198517872 hasConcept C143998085 @default.
• W3198517872 hasConcept C159110408 @default.
• W3198517872 hasConcept C185592680 @default.
• W3198517872 hasConcept C2776194525 @default.
• W3198517872 hasConcept C2776232967 @default.
• W3198517872 hasConcept C2776256026 @default.
• W3198517872 hasConcept C2777389519 @default.
• W3198517872 hasConcept C2779422266 @default.
• W3198517872 hasConcept C2780035454 @default.
• W3198517872 hasConcept C41685203 @default.
• W3198517872 hasConcept C502942594 @default.
• W3198517872 hasConcept C71924100 @default.
• W3198517872 hasConcept C98274493 @default.
• W3198517872 hasConceptScore W3198517872C143998085 @default.
• W3198517872 hasConceptScore W3198517872C159110408 @default.
• W3198517872 hasConceptScore W3198517872C185592680 @default.
• W3198517872 hasConceptScore W3198517872C2776194525 @default.
• W3198517872 hasConceptScore W3198517872C2776232967 @default.
• W3198517872 hasConceptScore W3198517872C2776256026 @default.
• W3198517872 hasConceptScore W3198517872C2777389519 @default.
• W3198517872 hasConceptScore W3198517872C2779422266 @default.
• W3198517872 hasConceptScore W3198517872C2780035454 @default.
• W3198517872 hasConceptScore W3198517872C41685203 @default.
• W3198517872 hasConceptScore W3198517872C502942594 @default.
• W3198517872 hasConceptScore W3198517872C71924100 @default.
• W3198517872 hasConceptScore W3198517872C98274493 @default.
• W3198517872 hasIssue "1" @default.
• W3198517872 hasLocation W31985178721 @default.
• W3198517872 hasOpenAccess W3198517872 @default.
• W3198517872 hasPrimaryLocation W31985178721 @default.
• W3198517872 hasRelatedWork W2063337289 @default.
• W3198517872 hasRelatedWork W2126298634 @default.
• W3198517872 hasRelatedWork W2167257097 @default.
• W3198517872 hasRelatedWork W2172288624 @default.
• W3198517872 hasRelatedWork W2404235140 @default.
• W3198517872 hasRelatedWork W2782578228 @default.
• W3198517872 hasRelatedWork W3138456635 @default.
• W3198517872 hasRelatedWork W3198517872 @default.
• W3198517872 hasRelatedWork W4206950539 @default.
• W3198517872 hasRelatedWork W4285086430 @default.
• W3198517872 hasVolume "7" @default.
• W3198517872 isParatext "false" @default.
• W3198517872 isRetracted "false" @default.
• W3198517872 magId "3198517872" @default.
• W3198517872 workType "article" @default.